Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis
Author:
Affiliation:
1. Suwon Korea
2. Seoul Korea
3. Busan Korea
4. Cheonan Korea
5. Anyang Korea
6. Daegu Korea
7. Daejeon Korea
8. Seongnam Korea
9. Cheongju Korea
10. Jeonju Korea
11. Bucheon Korea
12. Iksan Korea
Funder
CJ Healthcare
Publisher
Wiley
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15185/fullpdf
Reference30 articles.
1. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus;Vakil;Am J Gastroenterol,2006
2. Gastroesophageal reflux disease in Asia: a historical perspective and present challenges;Goh;J Gastroenterol Hepatol,2011
3. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review;El-Serag;Gut,2014
4. Prevalence of gastroesophageal reflux disease in a general population in Taiwan;Hung;J Gastroenterol Hepatol,2011
5. Prevalence of gastroesophageal reflux disease in Korea and associated health-care utilization: a national population-based study;Kim;J Gastroenterol Hepatol,2012
Cited by 80 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. AGA Clinical Practice Update on Integrating Potassium-Competitive Acid Blockers Into Clinical Practice: Expert Review;Gastroenterology;2024-09
2. Experimental drugs for erosive esophagitis: what is in the clinical development pipeline?;Expert Opinion on Investigational Drugs;2024-08-30
3. Safety of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease;Expert Opinion on Drug Metabolism & Toxicology;2024-08-27
4. Determination of Enantiomeric Impurity in Tegoprazan Drug Substance by HPLC;SEPARATION SCIENCE PLUS;2024-08-25
5. Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments;Current Gastroenterology Reports;2024-08-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3